peoniflorin and Hypersensitivity

peoniflorin has been researched along with Hypersensitivity* in 1 studies

Other Studies

1 other study(ies) available for peoniflorin and Hypersensitivity

ArticleYear
Paeoniflorin inhibits MRGPRX2-mediated pseudo-allergic reaction via calcium signaling pathway.
    Phytotherapy research : PTR, 2020, Volume: 34, Issue:2

    Mas-related G protein-coupled receptor-X2 (MRGPRX2) expressed on mast cells (MCs) has been shown to be a pivotal target for pseudo-allergic diseases. Therefore, MRGPRX2 might be a therapeutic target for allergic contact dermatitis, atopic dermatitis, and red man syndrome. Paeoniflorin (PF) was reported to have an antiinflammatory effect in neuroinflammation, enteritis, and so forth. In this study, we investigated the anti-pseudo-allergic effect of PF and the underlying molecular mechanisms. Our results showed that PF can suppress compound 48/80 (C48/80)-induced PCA and MCs degranulation in vivo, in a dose-dependent manner. Moreover, PF can reduce C48/80-induced calcium influx and suppress MC degranulation and chemokines release in vitro. PF can downregulate the phosphorylation levels of key kinases in PLCĪ³-regulated calcium influx and subsequent cytokine synthesis pathways. Our study revealed that PF could inhibit C48/80-induced allergic responses both in vivo and in vitro. As such, it may be regarded as a novel inhibitor for preventing MRGPRX2-mediated allergic diseases.

    Topics: Animals; Anti-Allergic Agents; Calcium Signaling; Cell Degranulation; Chemokines; Cytokines; Glucosides; Humans; Hypersensitivity; Male; Mast Cells; Mice; Mice, Inbred C57BL; Monoterpenes; Nerve Tissue Proteins; Receptors, G-Protein-Coupled; Receptors, Neuropeptide

2020